Paclitaxel | Docetaxel | Irinotecan | 10-DAB III | Baccatin | Sequoyitol | (2R,3S)-3-Phenylisoserine Hydrochloride | (4S,5R)-3-(tetra-butoxycarbonyl)-2,2-dimethyl-4-phenyl-oxazolidine-5-carboxylic acid | (4S,5R)-3-(3-benzoyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid--Shanghai Jinhe Bio-Tech Co., Ltd.

username：

password：


	Products Center

	API
	Paclitaxel (Semi-synthetic)
	Paclitaxel (Natural)
	Docetaxel Anhydrous
	Docetaxel Trihydrate
	Cabazitaxel
	Irinotecan HCl Trihydrate 99.5%
	Etoposide USP31
	Palonosetron Hydrochloride
	N-1 stage of Paclitaxel and Docetaxel
	7-Troc-Paclitaxel
	7,10-di-Troc-Docetaxel
	more...
	Main Intermediates
	10-Deacetylbaccatin III
	Baccatin III
	more...
	Side chain for Paclixel semi-Synthetic
	(4S,5R)-3-(N-benzoyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
	Side chain of Docetaxel
	(4S,5R)-3-(N-tert-butoxycarbony)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
	Side chain for Paclitaxel and Docetaxel
	(3R,4S)-3-hydroxy-4-phenyl-2-azetidinone
	Ethyl (2R,3S)-3-Phenylisoserine Ester
	more...

	Your location:Home>>R & D >>Patents

Jinhe dedicates itself to the development of industrialization technology for Anti-cancer drugs with our own intellectual property rights. Currently Jinhe owns three patents as below:

One of Irinotecan’s Intermediates & its Preparation method and preparation Method Of Irinotecan
Patent Number: ZL 2007 1 004 1525.X
Issue Date: Oct. 27, 2010

A Synthetic method of Docetaxel
Patent Number: ZL 2006 1 0116735.6
Issue Date: 30 July, 2008

A method of irinotecan hydrochloride
Patent Number: ZL2016 1 1234299.2
Issue Date: 8 March, 2019

Jinhe is actively applying other patents by its own technique, aiming at more self-developed intellectual properties to pave the way for long term development.